Thyroid News and Research

RSS

Endocrine Society announces winners of prestigious 2019 Laureate Awards

The Endocrine Society today announced it has chosen 13 leading endocrinologists as winners of its prestigious 2019 Laureate Awards, the top honors in the field.

6 Sep 2018

Link discovered between tumor genome changes and mortality risk across cancer types

Researchers have discovered a link between certain changes in the genome of a tumor and increased chances of death across multiple types of cancer.

5 Sep 2018

Study: Dementia symptoms likely to be most pronounced in winter and early spring

Adults both with and without Alzheimer’s disease have better cognition skills in the late summer and early fall than in the winter and spring, according to a new study published this week in PLOS Medicine by Andrew Lim of Sunnybrook Health Sciences Centre and the University of Toronto, Canada, and colleagues.

4 Sep 2018

A late-life surprise: Taking care of frail, aging parents

"This won't go on for very long," Sharon Hall said to herself when she invited her elderly mother, who'd suffered several small strokes, to live with her.

23 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

Standard hypothyroidism treatment inadequate in controlling crucial aspects of the condition

What if the standard treatment for hypothyroidism--insufficient thyroid hormone--is inadequate in controlling some crucial aspects of the condition? That's the provocative question asked, and answered affirmatively with objective data, in a study led by a Rush researcher presented this week in The Journal of Clinical Endocrinology & Metabolism.

22 Aug 2018

New study describes effect of radiation exposure on hormone deficiency in children

In a new study, University of Cincinnati researchers, in collaboration with Massachusetts General Hospital, have detailed the effect of radiation exposure on the development of hormone deficiency in pediatric and young adult patients treated for brain tumors.

21 Aug 2018

Two thyroid medications recalled by FDA

The United States Food and Drug Administration (FDA) have announced the recall of two thyroid medications due to issues with their ingredients.

16 Aug 2018

Removing the cancer label - overhaul in cancer classification proposed

Australian researchers have asked for changes in the way doctors tend to label low risk cancerous conditions as “cancer” leading to over treatment. Certain diagnoses such as localised prostate cancer or “stage 0” breast cancers need to be looked at say the researchers at the University of Sydney and Bond University to prevent aggressive treatment where it is not needed.

12 Aug 2018

Scientists turn to C. elegans for new model of peripheral neuropathy

Studying transthyretin amyloidoses-;a group of progressive nerve and cardiac degenerative diseases caused by the buildup of misfolded transthyretin proteins in the body-;has long been hampered by the lack of animal models of the disease.

9 Aug 2018

Doxorubicin drug causes heart toxicity by disrupting the immune system

Doxorubicin is a chemotherapy drug widely used in ovarian, bladder, lung, thyroid and stomach cancers, but it carries a harmful side effect. The drug causes a dose-dependent heart toxicity that can lead to congestive heart failure.

7 Aug 2018

FDA approves first therapy for patients with rare tumors of the adrenal gland

The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.

31 Jul 2018

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Study shows spillover effect of evidence-based opioid prescribing for major procedures

To curb the use of opioids after major elective operations and prevent these pain relievers from falling into the wrong hands, surgeons at the University of Michigan developed prescribing recommendations based on published medical evidence for one operation, gall bladder removal, and then discovered a spillover effect that led them to prescribe roughly 10,000 fewer pills for other major operations, according to study results appearing as an "article in press" on the website of the Journal of the American College of Surgeons ahead of print.

27 Jul 2018

Experts highlight the need to avoid overdiagnosis and 'excessive' treatment of thyroid cancer

More Americans are being diagnosed with thyroid cancer than ever before--over the past 25 years its incidence has tripled.

26 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

MicroRNA panel could categorize indeterminate thyroid nodule samples into malignant and benign

A panel of 19 microRNAs identified using next-generation sequencing could categorize indeterminate thyroid nodule samples into malignant and benign.

26 Jul 2018

How soon is soon enough to learn you have Alzheimer’s?

Jose Belardo of Lansing, Kan., spent most of his career in the U.S. Public Health Service. He worked on the front lines of disasters in such places as Haiti, Colombia, Nicaragua and the Dominican Republic. At home with his three kids and wife, Elaine, he’d always been unfailingly reliable, so when he forgot their wedding anniversary two years in a row, they both started to worry.

26 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved ZOMACTON for injection in four additional pediatric indications

20 Jul 2018

Thyroid News and Research

Endocrine Society announces winners of prestigious 2019 Laureate Awards

Link discovered between tumor genome changes and mortality risk across cancer types

Study: Dementia symptoms likely to be most pronounced in winter and early spring

A late-life surprise: Taking care of frail, aging parents

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Standard hypothyroidism treatment inadequate in controlling crucial aspects of the condition

New study describes effect of radiation exposure on hormone deficiency in children

Two thyroid medications recalled by FDA

Removing the cancer label - overhaul in cancer classification proposed

Scientists turn to C. elegans for new model of peripheral neuropathy

Doxorubicin drug causes heart toxicity by disrupting the immune system

FDA approves first therapy for patients with rare tumors of the adrenal gland

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Study shows spillover effect of evidence-based opioid prescribing for major procedures

Experts highlight the need to avoid overdiagnosis and 'excessive' treatment of thyroid cancer

CNDA approves KEYTRUDA for treatment of advanced melanoma

MicroRNA panel could categorize indeterminate thyroid nodule samples into malignant and benign

How soon is soon enough to learn you have Alzheimer’s?

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Snapping at new biotech breakthroughs with Gator Pro

Realizing the Importance of Medical Electronic Devices

Everything about SpatialOMx

Latest News

Antibodies eBook